Discover Luna Nanotech’s PLGA Nanoparticles uniquely functionalized with Methoxy PEG. These advanced PEGylated PLGA nanoparticles are engineered to enhance drug delivery applications by offering improved systemic circulation and minimizing non-specific protein adsorption, making them ideal for complex research.
Available sizes: 20 mg, 50mg, or custom
Price:
-
€
-
kr.
-
kr
-
kr
-
kr.
Send Request
The poly(lactic-co-glycolic acid) (PLGA) nanoparticles with Methoxy PEG surface modification from Luna Nanotech are designed to form robust nanostructures. These nanoparticles feature a hydrophobic core precisely encapsulated within a hydrophilic shell.
Key Features and Benefits of Methoxy PEG Coating:
- Enhanced Blood Half-Life: The incorporation of Methoxy PEG significantly improves the in vivo blood half-life of the nanoparticles. This is crucial for applications requiring extended systemic circulation.
- Reduced Non-Specific Protein Adsorption: Methoxy-PEG minimizes non-specific protein adsorption, which can lead to better biocompatibility and reduced immune response, improving delivery efficiency.
General PLGA Nanoparticle Characteristics:
- Composition: These nanoparticles are made with FDA-approved biocompatible and biodegradable PLGA polymer, ensuring their suitability for biological systems.
- Format: The product is supplied as a convenient lyophilized powder, facilitating easy storage and reconstitution.
Applications of This Technology: These versatile PEGylated PLGA nanoparticles can be effectively utilized in a range of scientific studies:
- Protein Delivery: Ideal for the controlled delivery of proteins, offering enhanced stability and circulation.
- Small Molecule Delivery: Suitable for encapsulating and delivering various small molecule drugs for targeted therapies.
- In Vivo and In Vitro Research: Their design makes them applicable for both laboratory-based studies and investigations within living organisms, particularly where extended circulation time is desired.
| pack-size |
|---|
